Generic Release of Gralise (Gabapentin tablets) will be launched in the First Quarter of 2024

Generic Release of Gralise (Gabapentin tablets) will be launched in the First Quarter of 2024 

Gabapentin is indicated for the management of postherpetic neuralgia. 

Gabapentin is not interchangeable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration. 

Gabapentin’s anticipated release date is in the first quarter of 2024.  

The post Generic Release of Gralise (Gabapentin tablets) will be launched in the First Quarter of 2024 appeared first on Carlisle Medical.